Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
de la Iglesia-San Sebastián I, Carbonell D, Bastos-Oreiro M, Pérez-Corral A, Bailén R, Chicano M, Muñiz P, Monsalvo S, Escudero-Fernández A, Oarbeascoa G, Fernández-Caldas P, Gómez-Centurión I, Pion M, Gayoso J, Anguita J, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C. de la Iglesia-San Sebastián I, et al. Among authors: diez martin jl. Transplant Cell Ther. 2024 Mar;30(3):306.e1-306.e12. doi: 10.1016/j.jtct.2023.12.672. Epub 2024 Jan 5. Transplant Cell Ther. 2024. PMID: 38184148 Free article.
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
Carbonell D, Monsalvo S, Catalá E, Pérez-Corral A, Villegas C, Falero C, Ruano G, Martinez M, Kwon M, Muñoz-Martínez C, Díez-Martín JL, Gayoso J, Anguita J. Carbonell D, et al. Among authors: diez martin jl. Blood Transfus. 2024 May;22(3):239-245. doi: 10.2450/BloodTransfus.542. Epub 2023 Sep 6. Blood Transfus. 2024. PMID: 38063787 Free PMC article.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Montoro J, Boumendil A, Finel H, Bramanti S, Castagna L, Blaise D, Dominietto A, Kulagin A, Yakoub-Agha I, Tbakhi A, Solano C, Giebel S, Gulbas Z, López Corral L, Pérez-Simón JA, Díez Martín JL, Sanz J, Farina L, Koc Y, Socié G, Arat M, Jurado M, Bermudez A, Labussière-Wallet H, Villalba M, Ciceri F, Martinez C, Nagler A, Sureda A, Glass B. Montoro J, et al. Among authors: diez martin jl. Transplant Cell Ther. 2024 Feb;30(2):210.e1-210.e14. doi: 10.1016/j.jtct.2023.11.021. Epub 2023 Dec 1. Transplant Cell Ther. 2024. PMID: 38043802
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Gavriilaki E, Sakellari I, Labopin M, Bornhäuser M, Hamladji RM, Casper J, Edinger M, Zák P, Yakoub-Agha I, Ciceri F, Schroeder T, Zuckerman T, Kobbe G, Yeshurun M, Narni F, Finke J, Diez-Martin JL, Berceanu A, Hilgendorf I, Verbeek M, Olivieri A, Savani B, Spyridonidis A, Nagler A, Mohty M. Gavriilaki E, et al. Among authors: diez martin jl. Bone Marrow Transplant. 2023 Oct;58(10):1084-1088. doi: 10.1038/s41409-023-02028-x. Epub 2023 Jul 7. Bone Marrow Transplant. 2023. PMID: 37420011
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.
Rodríguez-Macías G, Briz O, Cives-Losada C, Chillón MC, Martínez-Laperche C, Martínez-Arranz I, Buño I, González-Díaz M, Díez-Martín JL, Marin JJG, Macias RIR. Rodríguez-Macías G, et al. Among authors: diez martin jl. Cancers (Basel). 2023 Jun 11;15(12):3145. doi: 10.3390/cancers15123145. Cancers (Basel). 2023. PMID: 37370755 Free PMC article.
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Filippini Velázquez G, Labopin M, Tischer J, Raiola AM, Angelucci E, Kulagin AD, Galieni P, Bermúdez A, Bulabois CE, Kröger N, Díez-Martín JL, Kwon M, Nagler A, Schmid C, Ciceri F, Mohty M. Filippini Velázquez G, et al. Among authors: diez martin jl. Bone Marrow Transplant. 2023 Aug;58(8):907-915. doi: 10.1038/s41409-023-01985-7. Epub 2023 May 9. Bone Marrow Transplant. 2023. PMID: 37160941 Free PMC article.
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Gómez-Centurión I, Martin Rojas RM, Bailén R, Muñoz C, Sabell S, Oarbeascoa G, Fernández-Caldas P, Carbonell D, Gayoso J, Martínez-Laperche C, Buño I, Anguita J, Díez-Martin JL, Kwon M. Gómez-Centurión I, et al. Among authors: diez martin jl. Ann Hematol. 2023 Jun;102(6):1561-1567. doi: 10.1007/s00277-023-05206-5. Epub 2023 Apr 21. Ann Hematol. 2023. PMID: 37083956
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Nagler A, Labopin M, Dholaria B, Blaise D, Bondarenko S, Vydra J, Choi G, Rovira M, Reményi P, Meijer E, Bulabois CE, Diez-Martin JL, Yakoub-Agha I, Brissot E, Spyridonidis A, Sanz J, Patel A, Arat M, Bazarbachi A, Bug G, Savani BN, Giebel S, Ciceri F, Mohty M. Nagler A, et al. Among authors: diez martin jl. Br J Haematol. 2023 Jun;201(6):1169-1178. doi: 10.1111/bjh.18765. Epub 2023 Mar 22. Br J Haematol. 2023. PMID: 36949658
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma.
Bastos-Oreiro M, Sanz-Villanueva L, Muñiz P, Bailén R, Chicano M, Oarbeskoa G, Gómez I, Gutiérrez A, Iglesia I, Carbonell D, Diaz-Crespo FJ, Menarguez J, Diez-Martín JL, Kwon M, Buño I, Martínez-Laperche C. Bastos-Oreiro M, et al. Among authors: diez martin jl. Transplant Cell Ther. 2023 Jul;29(7):472.e1-472.e4. doi: 10.1016/j.jtct.2023.03.009. Epub 2023 Mar 14. Transplant Cell Ther. 2023. PMID: 36921917 Free article.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Martínez-López J, De la Cruz J, Gil-Manso R, Alegre A, Ortiz J, Llamas P, Martínez Y, Hernández-Rivas JÁ, González-Gascón I, Benavente C, Estival Monteliu P, Jiménez-Yuste V, Canales M, Bastos M, Kwon M, Valenciano S, Callejas-Charavia M, López-Jiménez J, Herrera P, Duarte R, Núñez Martín-Buitrago L, Sanchez Godoy P, Jacome Yerovi C, Martínez-Barranco P, García Roa M, Escolano Escobar C, Matilla A, Rosado Sierra B, Aláez-Usón MC, Quiroz-Cervantes K, Martínez-Chamorro C, Pérez-Oteyza J, Martos-Martinez R, Herráez R, González-Santillana C, Del Campo JF, Alonso A, de la Fuente A, Pascual A, Bustelos-Rodriguez R, Sebrango A, Ruiz E, Marcheco-Pupo EA, Grande C, Cedillo Á, Lumbreras C, Arroyo Barea A, Casas-Rojo JM, Calbacho M, Diez-Martín JL, García-Suárez J;   Asociación Madrileña de Hematología y Hemoterapia (AMHH). Martínez-López J, et al. Among authors: diez martin jl. Cancers (Basel). 2023 Feb 27;15(5):1497. doi: 10.3390/cancers15051497. Cancers (Basel). 2023. PMID: 36900296 Free PMC article.
189 results